Addressing Myopia and Ocular Complications
In Crystal Palace, childhood myopia, high myopia, and associated vision impairment and ocular complications are growing concerns. As specialists in children’s vision, we address these issues comprehensively, providing tailored solutions for optimal eye health.
about myopia
More children are getting myopia at younger ages – partly due to the rise in sedentary indoor lifestyles and increasing amount of time spent in near activities. The younger a child develops myopia, the further it evolves, the higher it becomes. Even with corrected lenses, their daily life may be impacted after a few months.
Studies showed that high myopia may lead to vision impairment that can no longer be corrected through standard lenses. It can even increase the risk of ocular complication later in life.
To make an appointment please use our online booking form or call us on 020 8766 7476.
myopia may impact children's well-being and development
- 80% of all learning occurs through vision*
- 1 out of 3 children can’t see the board clearly**
*Eyeglasses for Global Development: Bridging the Visual Divide: World Economic Forum, Social Entrepreneurs, EY Elliance; June 2016.
**Essilor See Change – Put Vision First global campaign 2017.
About Stellest
Stellest Lenses: Essilor’s latest innovation to slow down myopia progression in children.
Most of children are equipped with standard lenses, however those lenses only correct myopia but the eyes keep growing and so does myopia progression as well.
Essilor Stellest lenses correct myopia but also control its progression, with no compromises.
Essilor Stellest slow down myopia progression by 67% on average* compared to single vision lenses, when worn 12 hours a day.
To make an appointment please use our online booking form or call us on 020 8766 7476.
Compared to single vision lenses, when worn by children at least 12 hours a day every day. Bao J, Huange Y, Li X, Yang A, Zhou F, Wu J, Wang C, Li Y, Lim EW, Speigal DP, Drobe B, Chen H, 2022.
Spectacle lenses with Aspherical Lens for Myopia Control vs Single-Vision Spectacle: A randmoised clinical trial. JAMA Ophthalmol. 140(5), 472-478.